Saturday, July 11, 2026

Drug profile · INN

coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: elasomeran and imelasomeran)

coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: elasomeran and imelasomeran) (SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.

PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: elasomeran and imelasomeran)
Class
Route
Patents
0
Programs
0
Data quality
0.78

Quick answer

coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: elasomeran and imelasomeran) (SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: elasomeran and imelasomeran)
Brand SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) PARTIAL CHANGE APPROVAL

Approval history

Authority Status Date
PMDA approved

Frequently asked questions

What is coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: elasomeran and imelasomeran)?

coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: elasomeran and imelasomeran) (SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: elasomeran and imelasomeran)?

SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) PARTIAL CHANGE APPROVAL is a marketed brand name for coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: elasomeran and imelasomeran). Check FDA Drugs@FDA for the current US label holder and prescribing information.